Join
Live feed
·
INSIDERFilingvia Quantisnow
Moleculin Biotech Inc. logo

CEO and President Klemp Walter V converted options into 8,990 shares and covered exercise/tax liability with 2,190 shares, increasing direct ownership by 14% to 56,293 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
MBRX· Moleculin Biotech Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MBRX (Moleculin Biotech Inc.) and more on Quantisnow.

CEO and President Klemp Walter V converted options into 8,990 shares and covered exercise/tax liability with 2,190 shares, increasing direct ownership by 14% to 56,293 units (SEC Form 4) | Quantisnow